48 Ken Griffin Lilly(Eli) Trades
Ken Griffin acquired 853k Lilly(Eli) shares worth $717M. That's 0.60% of their equity portfolio (14th largest holding). The first Lilly(Eli) trade was made in Q2 2013. Since then Ken Griffin bought shares 60 more times and sold shares on 57 occasions. The stake costed the investor $137M, netting the investor a gain of 422% so far.
Avg closing price
Price range
Increased shares by 78.6% (+375k shares)
Q2 2025
Avg closing price
$777.40
Price range
$713.71
-
$898.95
Sold 21.8% shares (-133k shares)
Q1 2025
Avg closing price
$829.92
Price range
$725.72
-
$929.72
Increased shares by 184.1% (+396k shares)
Q4 2024
Avg closing price
$826.57
Price range
$727.53
-
$932.06
Sold 57.0% shares (-286k shares)
Q3 2024
Avg closing price
$899.87
Price range
$772.14
-
$960.02
Increased shares by 5.0% (+23.7k shares)
Q2 2024
Avg closing price
$799.92
Price range
$724.87
-
$909.04
Sold 62.6% shares (-799k shares)
Q1 2024
Avg closing price
$711.67
Price range
$592.20
-
$792.28
Increased shares by 67.9% (+516k shares)
Q4 2023
Avg closing price
$583.70
Price range
$525.19
-
$619.13
Increased shares by 39.1% (+214k shares)
Q3 2023
Avg closing price
$515.29
Price range
$434.70
-
$599.30
Increased shares by 118.4% (+296k shares)
Q2 2023
Avg closing price
$419.37
Price range
$350.74
-
$468.98
Increased shares by 41.5% (+73.3k shares)
Q1 2023
Avg closing price
$337.26
Price range
$310.63
-
$364.99
Sold 82.0% shares (-807k shares)
Q4 2022
Avg closing price
$354.56
Price range
$321.55
-
$374.76
Sold 15.6% shares (-182k shares)
Q3 2022
Avg closing price
$316.83
Price range
$296.48
-
$334.38
Increased shares by 2692.4% (+1.12M shares)
Q2 2022
Avg closing price
$300.17
Price range
$278.73
-
$327.27
Sold 68.9% shares (-92.5k shares)
Q1 2022
Avg closing price
$257.36
Price range
$234.69
-
$291.66
Increased shares by 53.9% (+47k shares)
Q4 2021
Avg closing price
$253.50
Price range
$224.85
-
$279.04
Sold 82.1% shares (-401k shares)
Q3 2021
Avg closing price
$246.81
Price range
$221.60
-
$272.71
Increased shares by 337.2% (+377k shares)
Q2 2021
Avg closing price
$200.87
Price range
$180.55
-
$233.54
Sold 80.4% shares (-459k shares)
Q1 2021
Avg closing price
$195.61
Price range
$164.32
-
$212.72
Sold 55.5% shares (-711k shares)
Q3 2020
Avg closing price
$154.77
Price range
$146.22
-
$169.13
Increased shares by 11303.6% (+1.27M shares)
Q2 2020
Avg closing price
$153.50
Price range
$136.42
-
$164.18
News about Lilly(Eli) & Co and Ken Griffin
Hedge Fund and Insider Trading News: Izzy Englander, Ken Griffin, Macellum Advisors, Bridgewater Associates, Coatue Management, Knighthead Capital Management, Brummer & Partners, Enviva Inc (EVA), Eli Lilly and Company (LLY), and More
Retailer Kohl’s Faces Fresh Call for Board Rejig from Activist Group Macellum (Reuters) Oct 13 (Reuters) – Activist investor group Macellum Advisors is once ...